In another significant legal win for vaccine risk awareness non-profit Informed Consent Action Network (ICAN), a new Freedom of Information Act disclosure from the Federal Food and Drug Administration (FDA) has revealed that the MMR vaccine was licensed based on clinical trials which in total had less than 1,000 participants and far more adverse reactions than previously acknowledged.
ICAN founder and host of the popular weekly medical show The High Wire, Del Bigtree said:
“It’s alarming that an appeal was required to get this information, but it’s more alarming that every time ICAN prevails in obtaining a FOIA disclosure from the FDA, CDC or HHS, we learn about another serious shortcoming in their duties to assure Americans’ health and health care,”
Some of the major concerns surrounding this largely untested vaccine are as follows:
- There were eight clinical trials that in total had less than 1,000 individuals, out of which only 342 children received the MMR vaccine
- The safety review period only tracked ‘adverse events’ for 42 days after injection
- More than half or a significant percent of all participants in each of the eight trials developed gastrointestinal symptoms and upper respiratory infections
- All adverse events were generically described as ‘other viruses’ and not considered in safety profile of licensure
- The control group received other vaccines for either rubella or measles and rubella, and none of the controls received a placebo (an inert substance such as a saline injection)
Check out the segment of The High Wire episode which discusses these major concerns regarding the MMR Vaccine trials below.
